Black Titan Corp (NASDAQ:BTTC)
| Market Cap | 2.72M-91.9% |
| Revenue (ttm) | 2.68M+158.8% |
| Net Income | 228.91K+119.2% |
| EPS | 0.03-49259.4% |
| Shares Out | 7.72M |
| PE Ratio | 11.74 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 81,018 |
| Open | 0.35 |
| Previous Close | 0.36 |
| Day's Range | 0.34 - 0.35 |
| 52-Week Range | 0.34 - 39.00 |
| Beta | 1.18 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 16, 2026 |
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
About BTTC
Black Titan Corporation was formed for the purpose of effecting a merger between Titan Pharmaceuticals Inc. and TalenTec Sdn Bhd. The company offers human capital management solutions and is also focused on strategic expansion into the digital asset and blockchain sectors.
$BTTC stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in BTTC holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by BTTC's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
BTTC Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New BTTC patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to BTTC from public contracts
Source: USAspending.gov
BTTC Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from BTTC’s recent data — informational, not investment advice
Recent Insider Activity
No Form 4 filings in the last 90 days.
